LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 171

Search options

  1. Article ; Online: SnapShot: Neuronal dysfunction in inflammation.

    Kneussel, Matthias / Friese, Manuel A

    Neuron

    2021  Volume 109, Issue 10, Page(s) 1754–1754.e1

    Abstract: Neuronal function relies on tightly controlled cytoskeleton transport with adaptive cargo trafficking as prerequisite for synaptic transmission. During inflammation in multiple sclerosis (MS) and experimental autoimmune encephalomyelitis (EAE), axonal ... ...

    Abstract Neuronal function relies on tightly controlled cytoskeleton transport with adaptive cargo trafficking as prerequisite for synaptic transmission. During inflammation in multiple sclerosis (MS) and experimental autoimmune encephalomyelitis (EAE), axonal transport efficiency declines, followed by neurodegeneration. Furthermore, neuroinflammation causes an imbalance between excitatory and inhibitory transmission, triggering synaptic dysfunction and loss. Recent data suggest that neuronal transport and synaptic deficits during neuroinflammation are functionally interconnected. To view this SnapShot, open or download the PDF.
    MeSH term(s) Animals ; Cytokines/metabolism ; Encephalomyelitis, Autoimmune, Experimental/immunology ; Encephalomyelitis, Autoimmune, Experimental/physiopathology ; Humans ; Multiple Sclerosis/immunology ; Multiple Sclerosis/physiopathology ; Neurons/immunology ; Neurons/physiology ; Synaptic Transmission
    Chemical Substances Cytokines
    Language English
    Publishing date 2021-05-20
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 808167-0
    ISSN 1097-4199 ; 0896-6273
    ISSN (online) 1097-4199
    ISSN 0896-6273
    DOI 10.1016/j.neuron.2021.03.005
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Book ; Online ; Thesis: Regulation und Expression der Komplementproteine Faktor H und FHL-1-Reconectin in physiologischen und pathologischen Prozessen

    Friese, Manuel A.

    2000  

    Author's details vorgelegt von Manuel Alexander Friese
    Language German
    Publishing country Germany
    Document type Book ; Online ; Thesis
    Thesis / German Habilitation thesis Hamburg, Univ., Diss., 2001
    Note Open Access
    HBZ-ID HT013587279
    Database ZB MED Catalogue: Medicine, Health, Nutrition, Environment, Agriculture

    More links

    Kategorien

  3. Article ; Online: Treatment of Cerebral Histiocytosis With Low Dose of Cobimetinib: A Report of 2 Cases.

    Schubert, Charlotte / Schiffmann, Insa / Farschtschi, Said C / Emile, Jean-François / Friese, Manuel A

    Neurology(R) neuroimmunology & neuroinflammation

    2024  Volume 11, Issue 3, Page(s) e200233

    Abstract: Objectives: Histiocytic disorders are pathologic expansions of myeloid cells in multiple organs, including the CNS. They share activation of the MAP kinase pathway due to either : Methods: We present 2 histiocytosis cases without : Results: In ... ...

    Abstract Objectives: Histiocytic disorders are pathologic expansions of myeloid cells in multiple organs, including the CNS. They share activation of the MAP kinase pathway due to either
    Methods: We present 2 histiocytosis cases without
    Results: In both cases, comprehensive analysis of the RAS-RAF-MEK-ERK signaling pathway secured the diagnosis. Treatment with the MEK inhibitor cobimetinib brought the disease to a complete halt. However, side effects such as thrombosis and serous macular edema made it necessary to reduce cobimetinib dosage. Low-dose cobimetinib maintenance medication was successful in preventing recurrence of histiocytic disease.
    Discussion: CNS involvement of histiocytic disorders can lead to detrimental neurologic symptoms. MEK inhibitors are effective treatment options for some of these patients. Since side effects are common, according to our cases we propose a low-dose treatment of 20 mg per day to balance treatment effects with side effects.
    Classification of evidence: This case report provides Class IV evidence. This is a single observational study without controls.
    MeSH term(s) Humans ; Proto-Oncogene Proteins B-raf/genetics ; Proto-Oncogene Proteins B-raf/metabolism ; Mutation ; Histiocytosis/drug therapy ; Histiocytosis/chemically induced ; Histiocytosis/pathology ; Protein Kinase Inhibitors/adverse effects ; Mitogen-Activated Protein Kinase Kinases ; Azetidines ; Piperidines
    Chemical Substances cobimetinib (ER29L26N1X) ; Proto-Oncogene Proteins B-raf (EC 2.7.11.1) ; Protein Kinase Inhibitors ; Mitogen-Activated Protein Kinase Kinases (EC 2.7.12.2) ; Azetidines ; Piperidines
    Language English
    Publishing date 2024-04-08
    Publishing country United States
    Document type Observational Study ; Case Reports ; Journal Article
    ZDB-ID 2767740-0
    ISSN 2332-7812 ; 2332-7812
    ISSN (online) 2332-7812
    ISSN 2332-7812
    DOI 10.1212/NXI.0000000000200233
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Case report: JAK inhibition as promising treatment option of fatal RVCLS due to

    Ufer, Friederike / Ziegler, Susanne M / Altfeld, Marcus / Friese, Manuel A

    Frontiers in neurology

    2023  Volume 14, Page(s) 1118369

    Abstract: Introduction: Autosomal dominant mutations in the C-terminal part of : Methods: We collected clinical data of an extended family with RVCLS (: Results: We report clinical details from 29 family members with 17 of them showing RVCLS symptoms. ... ...

    Abstract Introduction: Autosomal dominant mutations in the C-terminal part of
    Methods: We collected clinical data of an extended family with RVCLS (
    Results: We report clinical details from 29 family members with 17 of them showing RVCLS symptoms. Treatment of the index patient with ruxolitinib for >4 years was well-tolerated and clinically stabilized RVCLS activity. Moreover, we noticed normalization of initially elevated
    Discussion: We provide evidence that JAK inhibition as RVCLS treatment appears safe and could slow clinical worsening in symptomatic adults. These results encourage further use of JAK inhibitors in affected individuals together with monitoring of
    Language English
    Publishing date 2023-02-21
    Publishing country Switzerland
    Document type Case Reports
    ZDB-ID 2564214-5
    ISSN 1664-2295
    ISSN 1664-2295
    DOI 10.3389/fneur.2023.1118369
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Author Correction: Pathogenetic mechanisms and treatment targets in cerebral malaria.

    Hadjilaou, Alexandros / Brandi, Johannes / Riehn, Mathias / Friese, Manuel A / Jacobs, Thomas

    Nature reviews. Neurology

    2023  Volume 19, Issue 12, Page(s) 787

    Language English
    Publishing date 2023-11-06
    Publishing country England
    Document type Published Erratum
    ZDB-ID 2491514-2
    ISSN 1759-4766 ; 1759-4758
    ISSN (online) 1759-4766
    ISSN 1759-4758
    DOI 10.1038/s41582-023-00899-8
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Book ; Online ; Thesis: Deciphering cAMP-dependent mechanisms for T cell regulation in the context of multiple sclerosis

    Krieg, Paula Franziska Verfasser] / [Friese, Manuel A. [Akademischer Betreuer]

    2023  

    Author's details Paula Franziska Krieg ; Betreuer: Manuel A. Friese
    Keywords Naturwissenschaften ; Science
    Subject code sg500
    Language English
    Publisher Staats- und Universitätsbibliothek Hamburg Carl von Ossietzky
    Publishing place Hamburg
    Document type Book ; Online ; Thesis
    Database Digital theses on the web

    More links

    Kategorien

  7. Article ; Online: Widespread synaptic loss in multiple sclerosis.

    Friese, Manuel A

    Brain : a journal of neurology

    2016  Volume 139, Issue Pt 1, Page(s) 2–4

    MeSH term(s) Cerebral Cortex/pathology ; Dendritic Spines/pathology ; Female ; Humans ; Male ; Multiple Sclerosis/pathology ; Neurons/pathology
    Language English
    Publishing date 2016-01
    Publishing country England
    Document type Comment ; Journal Article
    ZDB-ID 80072-7
    ISSN 1460-2156 ; 0006-8950
    ISSN (online) 1460-2156
    ISSN 0006-8950
    DOI 10.1093/brain/awv349
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Astrocytic uptake of posttranslationally modified amyloid-β leads to endolysosomal system disruption and induction of pro-inflammatory signaling.

    Wirth, Sarah / Schlößer, Annika / Beiersdorfer, Antonia / Schweizer, Michaela / Woo, Marcel S / Friese, Manuel A / Lohr, Christian / Grochowska, Katarzyna M

    Glia

    2024  

    Abstract: The disruption of astrocytic catabolic processes contributes to the impairment of amyloid-β (Aβ) clearance, neuroinflammatory signaling, and the loss of synaptic contacts in late-onset Alzheimer's disease (AD). While it is known that the ... ...

    Abstract The disruption of astrocytic catabolic processes contributes to the impairment of amyloid-β (Aβ) clearance, neuroinflammatory signaling, and the loss of synaptic contacts in late-onset Alzheimer's disease (AD). While it is known that the posttranslational modifications of Aβ have significant implications on biophysical properties of the peptides, their consequences for clearance impairment are not well understood. It was previously shown that N-terminally pyroglutamylated Aβ3(pE)-42, a significant constituent of amyloid plaques, is efficiently taken up by astrocytes, leading to the release of pro-inflammatory cytokine tumor necrosis factor α and synapse loss. Here we report that Aβ3(pE)-42, but not Aβ1-42, gradually accumulates within the astrocytic endolysosomal system, disrupting this catabolic pathway and inducing the formation of heteromorphous vacuoles. This accumulation alters lysosomal kinetics, lysosome-dependent calcium signaling, and upregulates the lysosomal stress response. These changes correlate with the upregulation of glial fibrillary acidic protein (GFAP) and increased activity of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB). Treatment with a lysosomal protease inhibitor, E-64, rescues GFAP upregulation, NF-κB activation, and synapse loss, indicating that abnormal lysosomal protease activity is upstream of pro-inflammatory signaling and related synapse loss. Collectively, our data suggest that Aβ3(pE)-42-induced disruption of the astrocytic endolysosomal system leads to cytoplasmic leakage of lysosomal proteases, promoting pro-inflammatory signaling and synapse loss, hallmarks of AD-pathology.
    Language English
    Publishing date 2024-04-17
    Publishing country United States
    Document type Journal Article
    ZDB-ID 639414-0
    ISSN 1098-1136 ; 0894-1491
    ISSN (online) 1098-1136
    ISSN 0894-1491
    DOI 10.1002/glia.24539
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Pathogenetic mechanisms and treatment targets in cerebral malaria.

    Hadjilaou, Alexandros / Brandi, Johannes / Riehn, Mathias / Friese, Manuel A / Jacobs, Thomas

    Nature reviews. Neurology

    2023  Volume 19, Issue 11, Page(s) 688–709

    Abstract: Malaria, the most prevalent mosquito-borne infectious disease worldwide, has accompanied humanity for millennia and remains an important public health issue despite advances in its prevention and treatment. Most infections are asymptomatic, but a small ... ...

    Abstract Malaria, the most prevalent mosquito-borne infectious disease worldwide, has accompanied humanity for millennia and remains an important public health issue despite advances in its prevention and treatment. Most infections are asymptomatic, but a small percentage of individuals with a heavy parasite burden develop severe malaria, a group of clinical syndromes attributable to organ dysfunction. Cerebral malaria is an infrequent but life-threatening complication of severe malaria that presents as an acute cerebrovascular encephalopathy characterized by unarousable coma. Despite effective antiparasite drug treatment, 20% of patients with cerebral malaria die from this disease, and many survivors of cerebral malaria have neurocognitive impairment. Thus, an important unmet clinical need is to rapidly identify people with malaria who are at risk of developing cerebral malaria and to develop preventive, adjunctive and neuroprotective treatments for cerebral malaria. This Review describes important advances in the understanding of cerebral malaria over the past two decades and discusses how these mechanistic insights could be translated into new therapies.
    MeSH term(s) Animals ; Humans ; Malaria, Cerebral/complications ; Malaria, Cerebral/drug therapy ; Brain Diseases ; Coma
    Language English
    Publishing date 2023-10-19
    Publishing country England
    Document type Journal Article ; Review ; Research Support, Non-U.S. Gov't
    ZDB-ID 2491514-2
    ISSN 1759-4766 ; 1759-4758
    ISSN (online) 1759-4766
    ISSN 1759-4758
    DOI 10.1038/s41582-023-00881-4
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Book ; Online ; Thesis: Stimulation and inhibition of protein-protein interactions to modulate autophagic pathways

    Küver, Daniel Verfasser] / [Friese, Manuel A. [Akademischer Betreuer]

    2022  

    Author's details Daniel Küver ; Betreuer: Manuel Friese
    Keywords Medizin, Gesundheit ; Medicine, Health
    Subject code sg610
    Language English
    Publisher Staats- und Universitätsbibliothek Hamburg Carl von Ossietzky
    Publishing place Hamburg
    Document type Book ; Online ; Thesis
    Database Digital theses on the web

    More links

    Kategorien

To top